(Q46988238)

27 December 2017

title

The case against universal varicella vaccination (English)

1 reference

27 December 2017

Gary S Goldman

1

0 references

publication date

1 September 2006

1 reference

27 December 2017

International Journal of Toxicology

published in

1 reference

27 December 2017

volume

25

1 reference

27 December 2017

issue

5

1 reference

27 December 2017

page(s)

313-317

1 reference

27 December 2017

Cell-Mediated Immunity to Varicella-Zoster Virus

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10915810600870591

Control of varicella: why is a two-dose schedule necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810600870591

Immunologic Evidence of Reinfection with Varicella-Zoster Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810600870591

Varicella vaccine: the Japanese experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810600870591

Herpes zoster ophthalmicus in an otherwise-healthy child

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810600870591

Postmarketing evaluation of the safety and effectiveness of varicella vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810600870591

Modelling the impact of immunization on the epidemiology of varicella zoster virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810600870591

Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810600870591

Recurrent papular urticaria after varicella immunization in a fifteen-month-old girl

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810600870591

Uveitis associated with varicella virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810600870591

Outbreak of varicella at a day-care center despite vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810600870591

Incidence of herpes zoster among children and adolescents in a community with moderate varicella vaccination coverage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810600870591

Universal varicella vaccination: efficacy trends and effect on herpes zoster

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810600870591

Secondary transmission of varicella vaccine virus in a chronic care facility for children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810600870591

Immunogenicity and safety of two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810600870591

Cost-effectiveness of a routine varicella vaccination program for US children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810600870591

Herpes zoster virus sclerokeratitis and anterior uveitis in a child following varicella vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810600870591

Decline in mortality due to varicella after implementation of varicella vaccination in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810600870591

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810600870591

IgE-mediated systemic reactions to gelatin included in the varicella vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810600870591

Varicella zoster virus meningitis in a previously immunized child

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810600870591

Varicella disease after introduction of varicella vaccine in the United States, 1995-2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810600870591

Contagiousness of varicella in vaccinated cases: a household contact study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810600870591

Acute cerebellar ataxia with abnormal MRI lesions after varicella vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810600870591

Incidence of Herpes Zoster in Pediatricians and History of Reexposure to Varicella-zoster Virus in Patients with Herpes Zoster

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810600870591

Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810600870591

Prevalence of antibodies to four herpesviruses among adults with glioma and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810600870591

Postlicensure safety surveillance for varicella vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810600870591

The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810600870591

10.1080/10915810600870591

21 January 2018

Identifiers

DOI

1 reference

27 December 2017

1 reference

27 December 2017